Pulmonary & Critical Care Medicine Fellowship
Resources for Fellows -- Transplant Service
(All files listed below are in .pdf format and require Acrobat Reader)
Syllabus -- UW NetID Required to Access These Files
A randomized trial of inhaled cyclosporine in lung-transplant recipients.
A review of lung transplant donor acceptability criteria.
Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans.
Allograft rejection after lung transplantation.
Assessment of survival benefit after lung transplantation by patient diagnosis.
Azithromycin Reverses Airflow Obstruction in Established Bronchiolitis Obliterans Syndrome.
Bronchiolitis obliterans after human lung transplantation.
Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria.
Immunosuppressive therapy after human lung transplantation.
Impact of secondary pulmonary hypertension on lung transplant outcome.
International guidelines for the selection of lung transplant candidates: 2006 update--A concensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation.
Living donor lung transplantation selection, technique, and outcome.
Lung transplantation opportunities for research and clinical advancement
Lung transplantation disease-specific considerations for referral
Medical complications of lung transplantation.
Non-heart-beating donors in thoracic transplantation.
Noninfectious pulmonary complications after lung transplantation.
Paediatric lung transplantation.pdf
Post-transplant bronchiolitis obliterans.
Pulmonary complications of solid organ and hematopoietic stem cell transplantation.
Registry of the International Society for Heart and Lung Transplantation: twenty-third official Adult Lung and Heart-Lung Transplantation Report--2006.
Risk quantification of early outcome after lung transplantation: donor, recipient, operative and post-transplant parameters.
The effect of primary graft dysfunction on survival after lung transplantation.
The predictive value of bronchiolitis obliterans syndrome stage O-p.
Update in transplantation 2005.
Cystic fibrosis adult care: consensus conference report.
Cystic Fibrosis Since 1938.
Lung Transplantation for Cystic Fibrosis Patients with Burkhloderia cepacia complex.
Risk Factors for Death of Patients with Cystic Fibrosis Awaiting Lung Transplantation.
Update in cystic fibrosis 2005.
Use of Lung Transplantation Survival Models to Refine Patient Selection in Cystic Fibrosis.
A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema.
Patients at high risk of death after lung-volume-reduction-surgery.
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.
Clinical advances in the diagnosis and therapy of the interstitial lung diseases.
Effect of preoperative pulmonary artery pressure on early survival after lung transplantation for idiopathic pulmonary fibrosis.
Idiopathic pulmonary fibrosis: current trends in management.
Impact of recipient age and procedure type on survival after lung transplantation for pulmonary fibrosis.
Lung transplantation for interstitial lung disease.
Medical treatment for pulmonary fibrosis: current trends, concepts and prospects.
Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis.
The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis.
The clinical course of patients with idiopathic pulmonary fibrosis.
Evaluation and management of the patient with pulmonary arterial hypertension.
Long-term intravenous epoprostenol infusion in primary pulmonary hypertension.
Pulmonary arterial hypertension.
Treatment of pulmonary arterial hypertension.